Categories: Wire Stories

Suzano reinforces commitment to China at Shanghai Pulp Week 2022

Suzano unveils plans for a new �Innovability Hub’ in Shanghai and initiates the establishment of the Sustainability Development Committee with the China Pulp and Paper Industry Chamber of Commerce

SÃO PAULO & NEW YORK & SHANGHAI–(BUSINESS WIRE)–Suzano, the world’s largest hardwood producer, has underlined its commitment to the Chinese market and its customers, and the pursuit of environmental solutions based on the bioeconomy at Shanghai Pulp Week 2022.

CEO Walter Schalka led Suzano’s presentation at the annual meeting, showcasing the company’s long-term plans for collaboration with the Chinese industry to meet the growing demand for pulp-based products and the critical role Suzano can play in helping the country reach its decarbonization goals.

To demonstrate its commitment to the Chinese market, Suzano unveiled plans to launch a new ‘Innovability Hub’ at the heart of Shanghai’s technology and innovation district. The new hub is designed to boost customer relations in the region, alongside broader collaboration to advance the pursuit of sustainable solutions through innovation.

Suzano also announced the initiative of establishing a Sustainability Development Committee (SDC) under the China Pulp and Paper Industry Chamber of Commerce (CPICC).

Walter Schalka, CEO of Suzano, commented:

“Chinese demand for hardwood pulp is expected to increase exponentially in the coming years. Suzano is well placed to deliver on the organic growth opportunity with our extensive commercial ties in China.

“As a company, we are hugely committed to ongoing R&D in sustainable innovation, and our Innovability Hub is the next step for us as we prioritise nature-based solutions which align with China’s 2060 Carbon Neutrality target.”

Pablo Machado, President of Asia Business (Beyond Pulp) at Suzano, said:

“We are excited to share our plans for the SDC under the CPICC as well as our new Innovability Hub. These projects are designed to help us work more closely with local partners to boost sustainability standards in the industry and develop ground-breaking, nature-based solutions which meet modern demands.”

Jeff Yang, President of Asia Business (Pulp) at Suzano and Vice Chairman of CPICC, added:

“Suzano has been an important sponsor of Shanghai Pulp Week for years. Walter’s speech which outlined the company’s pledge to ensuring the long-lasting competitiveness for non-integrated paper producers in China was well received by our delegates and local industry participants.”

Contacts

Suzano
Jeanne Wu

jeannewu@suzanoasia.com

Hawthorn Advisors
Jamie Plotnek

suzano@hawthornadvisors.com

Alex

Recent Posts

Fabrinet Announces Third Quarter Fiscal Year 2024 Financial Results

Exceeds Guidance Ranges with Record Revenue and Net Income Per Share BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN),…

60 mins ago

South Korea Data Center Market Investment Analysis Report 2024-2029: Opportunities in IT, Electrical, Mechanical Infrastructure, General Construction, and Tier Standards – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "South Korea Data Center Market - Investment Analysis & Growth Opportunities 2024-2029" report…

4 hours ago

Revitalized “Marco Polo” Opera Celebrates Sino-Italian Ties at Guangzhou Opera House

GUANGZHOU, China--(BUSINESS WIRE)--On May 3rd and 4th, the Guangzhou Opera House welcomed nearly 200 international…

5 hours ago

BrainChip Earns Australian Patent for Improved Spiking Neural Network

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first…

5 hours ago

NetApp Appoints Market Growth and Revenue Operations Leader, Dallas Olson to Chief Commercial Officer Role

SAN JOSE, Calif.--(BUSINESS WIRE)--NetApp (NASDAQ: NTAP), the intelligent data infrastructure company, today announced Dallas Olson…

6 hours ago

Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies

BEIJING--(BUSINESS WIRE)--#Antibody--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on…

7 hours ago